ACR Convergence 2025

October 24-29, 2025. Chicago, Illinois.

View by Number View by Title View Sessions

Abstract Number: 2153

Giant Coronaries in Children with Kawasaki Disease: A Single Centre Experience
Abstract Number: 2154

Whole-Body MRI Findings in a Cohort of Children with Chronic Nonbacterial Osteomyelitis
Abstract Number: 2155

A Novel TNFAIP3 Mutation Associated with Large Vessel Vasculitis: Expanding the Phenotypic Spectrum of A20 Haploinsufficiency
Abstract Number: 2156

Bridging the Gap: Juvenile Spondyloarthritis (JSpA) vs. Chronic Non-Bacterial Osteomyelitis (CNO)
Abstract Number: 2157

Optimizing the Diagnosis and Treatment of Kawasaki Disease-Associated Macrophage Activation Syndrome: A Clinical Cohort and Literature Analysis
Abstract Number: 2158

Evaluating Nailfold Capillary Changes as Indicators of Disease Activity in Juvenile Dermatomyositis
Abstract Number: 2159

Teaching Musculoskeletal Ultrasound Improves Knowledge and Confidence in the Knee Exam: A Pilot Session with Internal Medicine Trainees
Abstract Number: 2160

RadRheum: Improving Resident and Medical Student Musculoskeletal Radiology Interpretation Skills Utilizing an Interactive Module
Abstract Number: 2161

Perceptions of the Importance of Pediatric Rheumatology Education in Pediatric Residency: A Needs Assessment
Abstract Number: 2162

An Updated Needs Assessment for the Virtual Rheumatology Program for Fellows in Training (V-FIT)
Abstract Number: 2163

Enhancing Post-Conference Engagement Through Expert Q&A: A Pilot Collaboration Between ACR Convergence & theMednet.org
Abstract Number: 2164

East Meets West: A Novel Tofu-Pasta-Cardstock Phantom Model for Teaching Ultrasound-Guided Procedures
Abstract Number: 2165

Targeted Needs Assessment of Provider Medical Knowledge of Juvenile Scleroderma, a Mixed Methods Study
Abstract Number: 2166

Clinical Disease Activity Index (CDAI) for Rheumatoid Arthritis: A Clinical Educational Workshop
Abstract Number: 2167

Rheum4Games: A Game-Based Rheumatology Board Review for Internal Medicine Residents

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].